# Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies

> **NCT00689884** · NA · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 7 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **DRUG:** Pegfilgrastim

## Key facts

- **NCT ID:** NCT00689884
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of enrollment.
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689884, "Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00689884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*